Seguimiento de pacientes con VIH durante la pandemia de la Covid-19 en la región de Callao, Perú
DOI:
https://doi.org/10.20453/rmh.v35i2.4989Palavras-chave:
HIV , public health, viral load, allergy and immunologyResumo
The diagnosis of human immunodeficiency virus (HIV) is key for the initiation of antiretroviral therapy (ART). Viral load (VL) values and other immunological components are essential for the follow-up and prognosis of people with HIV. The aim of the study was to evaluate patients with a confirmatory diagnosis of HIV residing in the Callao region. Prospective study, in which 289 adult residents of the Callao region were evaluated, confirmatory and post ART treatment measurements were performed. For the difference of means, Student’s T-test for paired samples was calculated, considering p<0.05 as statistical significant. People who received ART showed a significant decrease in VL values and an increase in CD4+. There have been a successful disease management and control of the HIV-infected population in Callao.
Downloads
Referências
UNAIDS. Global HIV & AIDS statistics — Fact sheet. (n.d.). https://www.unaids.org/es/resources/fact-sheet
Carracedo S, Palmero A, Neil M, Hasan-Granier A, Saenz C, Reveiz L. El panorama de los ensayos clínicos sobre COVID-19 en América Latina y el Caribe: evaluación y desafíos. Rev Panam Salud Publica. 2021; 45:e33. Doi:10.26633/RPSP.2020.177
World Health Organization. WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms. Policy Brief: HIV Testing Services. Geneva: World Health Organization. 2019. Disponible en: file:///C:/Users/Administrador/Downloads/WHO-CDS-HIV-19.30-eng.pdf
Soto-Silva A. La infección por VIH en tiempos de pandemia: Muchos retrocesos, innumerables desafíos. Rev Chilena Infectol. 2022; 39 (3): 287–293. Doi:10.4067/s0716-10182022000200287
Ochodo EA, Olwanda EE, Deeks JJ, Mallett S. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. The Cochrane database of systematic reviews. 2022; 3(3): CD013208. Doi: 10.1002/14651858.CD013208.pub2
Ochodo EA, Guleid F, Deeks JJ, Mallett S. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less. The Cochrane database of systematic reviews. 2021; 8(8): CD013207. Doi: 10.1002/14651858.CD013207.pub2
Moyo S, Mohammed T, Wirth KE, Prague M, Bennett K, Holme MP, et al. Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable. J Clin Microbiol. 2016; 54(12): 3050–3055. hDoi:10.1128/JCM.01594-16
Chihana ML, Huerga H, Van Cutsem G, Ellman T, Wanjala S, Masiku C, et al. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries. PloS One. 2018; 13(11): e0207656. Doi: 10.1371/journal.pone.0207656
Maman D, Zeh C, Mukui I, Kirubi B, Masson S, Opolo V, et al. Cascade of HIV care and population viral suppression in a high-burden region of Kenya. AIDS (London, England). 2015; 29(12): 1557–1565. Doi:10.1097/QAD.0000000000000741
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Cinthya Vasquez-Velasquez, William Cassa-Loayza, Daisy Farroñay-Isique, Gustavo F Gonzales, Diego Fano-Sizgorich
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os autores cedem os seus direitos à RMH para que estas possam divulgar o artigo através dos meios ao seu alcance. A revista fornecerá formulários de declaração de autoria e autorização para a publicação do artigo, que deverão ser entregues juntamente com o manuscrito. Os autores conservam o direito de partilhar, copiar, distribuir, executar e comunicar publicamente o seu artigo, ou parte dele, mencionando a publicação original na revista.
